REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Nisarg Biosciences Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Nisarg Biosciences Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Nisarg Biosciences Private Limited is an unlisted company, incorporated on 25/06/2004. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24233TG2004PTC043541 and registration number is 043541. The company is a professional, scientific and technical company, it is engaged in scientific research and development.

Legal Address
Shed No 30, Plot No 92 Phase I, Ida, Cherlapally
Rangareddy; Andhra Pradesh; Postal Code: 500051

Contact Details: Purchase the Nisarg Biosciences Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Nisarg Biosciences Private Limited report to view the information.
Registered Capital:
Purchase the Nisarg Biosciences Private Limited report to view the information.
Incorporation Date:
June 25, 2004
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
41.7%
Purchase this report to view the information.
11.66%
Company Performance
Financial values in the chart are available after Nisarg Biosciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-81.93%▼
Total operating revenue
-82.2%▼
Operating profit (EBIT)
-11.73%▼
EBITDA
1.4%▲
Net Profit (Loss) for the Period
9.88%▲
Total assets
75.25%▲
Total equity
6.19%▲
Operating Profit Margin (ROS)
1.51%▲
Net Profit Margin
1.8%▲
Return on Equity (ROE)
-0.44%▼
Debt to Equity Ratio
-70.32%▼
Quick Ratio
0.22%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo